1. Home
  2. CASH vs AVDL Comparison

CASH vs AVDL Comparison

Compare CASH & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASH
  • AVDL
  • Stock Information
  • Founded
  • CASH 1954
  • AVDL 2015
  • Country
  • CASH United States
  • AVDL Ireland
  • Employees
  • CASH N/A
  • AVDL N/A
  • Industry
  • CASH Major Banks
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASH Finance
  • AVDL Health Care
  • Exchange
  • CASH Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • CASH 1.7B
  • AVDL 1.4B
  • IPO Year
  • CASH N/A
  • AVDL 1996
  • Fundamental
  • Price
  • CASH $76.40
  • AVDL $15.76
  • Analyst Decision
  • CASH Buy
  • AVDL Strong Buy
  • Analyst Count
  • CASH 2
  • AVDL 8
  • Target Price
  • CASH $91.00
  • AVDL $20.88
  • AVG Volume (30 Days)
  • CASH 140.0K
  • AVDL 1.3M
  • Earning Date
  • CASH 10-22-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • CASH 0.26%
  • AVDL N/A
  • EPS Growth
  • CASH 4.46
  • AVDL N/A
  • EPS
  • CASH 6.92
  • AVDL N/A
  • Revenue
  • CASH $733,796,000.00
  • AVDL $221,075,000.00
  • Revenue This Year
  • CASH $18.96
  • AVDL $63.77
  • Revenue Next Year
  • CASH $5.11
  • AVDL $29.91
  • P/E Ratio
  • CASH $11.10
  • AVDL N/A
  • Revenue Growth
  • CASH 5.46
  • AVDL 132.35
  • 52 Week Low
  • CASH $62.79
  • AVDL $6.38
  • 52 Week High
  • CASH $86.00
  • AVDL $16.66
  • Technical
  • Relative Strength Index (RSI)
  • CASH 44.69
  • AVDL 75.50
  • Support Level
  • CASH $77.33
  • AVDL $14.21
  • Resistance Level
  • CASH $79.13
  • AVDL $15.41
  • Average True Range (ATR)
  • CASH 2.00
  • AVDL 0.54
  • MACD
  • CASH 0.11
  • AVDL -0.03
  • Stochastic Oscillator
  • CASH 33.07
  • AVDL 99.16

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: